Conflict of Interest and Medical Innovation Ensuring Integrity While Facilitating Innovation in Medical Research: Workshop Summary (2014) / Chapter Skim
Currently Skimming:
Appendix A: Workshop Agenda
Appendix A: Workshop Agenda
Pages 53-58
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 53... ...
• To examine the effect of current conflict of interest policies on medical innovation. • To identify best practices and potential solutions for facilitating innovation under current conflict of interest policy implementation while still ensuring scientific integrity and public trust.
|
From page 54... ...
Terry, Roundtable Co-Chair and Workshop Chair President and Chief Executive Officer Genetic Alliance 8:45–10:45 SESSION I: CURRENT LANDSCAPE FOR MEDICAL INNOVATION Moderator: Allen S Lichter Chief Executive Officer American Society of Clinical Oncology 8:45–9:15 Conflict of Interest and Medical Innovation Bernard Lo President Greenwall Foundation 9:15–9:45 Enhancing the Development of Novel Medical Products and Clinical Applications Neal H
|
From page 55... ...
Pierce Senior Director, Science Policy and Regulatory Counsel AAMC 11:30–11:45 Government Perspective Krishna Balakrishnan Senior Technology Manager, Office of Strategic Alliances National Center for Advancing Translational Sciences 11:45 A.M.– Discussion with Speakers and Attendees 12:25 P.M. 12:25–1:10 WORKING LUNCH 1:10–2:10 SESSION III: PUBLIC PERCEPTIONS OF CONFLICT OF INTEREST Moderator: Jill Hartzler Warner Acting Associate Commissioner for Special Medical Programs Food and Drug Administration
|
From page 56... ...
McMurry-Heath Associate Director for Science Center for Devices and Radiological Health Food and Drug Administration 2:15–2:20 Tech Transfer Todd Sherer Associate Vice President for Research Executive Director, Office of Technology Transfer Emory University 2:20–2:25 Industry Paul Billings Chief Medical Officer Life Technologies Corporation
|
From page 57... ...
Lichter Chief Executive Officer American Society of Clinical Oncology 2:45–3:50 Roundtable Discussion with Speakers and Attendees 3:50–4:05 BREAK 4:05–5:00 SESSION V: CONVERGENCE ON CONFLICT OF INTEREST Moderator: Sharon Terry President and Chief Executive Officer Genetic Alliance
|
From page 58... ...
McMurry-Heath Associate Director for Science Center for Devices and Radiological Health Food and Drug Administration Heather Pierce Senior Director, Science Policy and Regulatory Counsel Association of American Medical Colleges 4:50–5:00 SESSION VI: CONCLUSION 4:50–5:00 CONCLUDING REMARKS Sharon F Terry, Roundtable Co-Chair and Workshop Chair President and Chief Executive Officer Genetic Alliance 5:00 ADJOURN
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.